| 1 | 1 | | 89R1261 JG-F |
|---|
| 2 | 2 | | By: Harrison H.B. No. 855 |
|---|
| 3 | 3 | | |
|---|
| 4 | 4 | | |
|---|
| 5 | 5 | | |
|---|
| 6 | 6 | | |
|---|
| 7 | 7 | | A BILL TO BE ENTITLED |
|---|
| 8 | 8 | | AN ACT |
|---|
| 9 | 9 | | relating to promoting, prescribing, administering, or dispensing |
|---|
| 10 | 10 | | prescription drugs for off-label use. |
|---|
| 11 | 11 | | BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|---|
| 12 | 12 | | SECTION 1. Subtitle A, Title 6, Health and Safety Code, is |
|---|
| 13 | 13 | | amended by adding Chapter 446 to read as follows: |
|---|
| 14 | 14 | | CHAPTER 446. OFF-LABEL USE OF PRESCRIPTION DRUGS |
|---|
| 15 | 15 | | Sec. 446.001. DEFINITIONS. In this chapter: |
|---|
| 16 | 16 | | (1) "Off-label use" means the use of a prescription |
|---|
| 17 | 17 | | drug approved for use by the United States Food and Drug |
|---|
| 18 | 18 | | Administration in a manner other than the approved use. |
|---|
| 19 | 19 | | (2) "Pharmacist" means a person licensed by the Texas |
|---|
| 20 | 20 | | State Board of Pharmacy to practice pharmacy. |
|---|
| 21 | 21 | | (3) "Physician" means an individual licensed by the |
|---|
| 22 | 22 | | Texas Medical Board to practice medicine in this state. |
|---|
| 23 | 23 | | Sec. 446.002. APPLICABILITY. This chapter applies only to |
|---|
| 24 | 24 | | the promoting, prescribing, administering, and dispensing of a |
|---|
| 25 | 25 | | prescription drug the United States Food and Drug Administration |
|---|
| 26 | 26 | | has approved for human use. |
|---|
| 27 | 27 | | Sec. 446.003. PROHIBITED DISCIPLINARY ACTION AGAINST |
|---|
| 28 | 28 | | PHYSICIAN'S OR PHARMACIST'S LICENSE. (a) Except as provided by |
|---|
| 29 | 29 | | Subsection (b), the state agency with licensing or regulatory |
|---|
| 30 | 30 | | authority over a physician or pharmacist may not revoke, fail to |
|---|
| 31 | 31 | | renew, suspend, or take any other adverse action against a |
|---|
| 32 | 32 | | physician's or pharmacist's license based solely on the physician |
|---|
| 33 | 33 | | or pharmacist: |
|---|
| 34 | 34 | | (1) prescribing, administering, or dispensing a |
|---|
| 35 | 35 | | prescription drug for off-label use to treat a patient; or |
|---|
| 36 | 36 | | (2) communicating or otherwise promoting to a patient |
|---|
| 37 | 37 | | an off-label use of a prescription drug. |
|---|
| 38 | 38 | | (b) The state agency with licensing or regulatory authority |
|---|
| 39 | 39 | | over a physician or pharmacist may revoke, fail to renew, suspend, |
|---|
| 40 | 40 | | or take any other adverse action against a physician's or |
|---|
| 41 | 41 | | pharmacist's license based on conduct described by Subsection |
|---|
| 42 | 42 | | (a)(1) or (2) if, after notice and hearing, the agency proves beyond |
|---|
| 43 | 43 | | a reasonable doubt that: |
|---|
| 44 | 44 | | (1) the conduct caused the physician's or pharmacist's |
|---|
| 45 | 45 | | patient to suffer physical harm; and |
|---|
| 46 | 46 | | (2) the initial onset of the patient's physical harm |
|---|
| 47 | 47 | | occurred not later than three years after the date of the |
|---|
| 48 | 48 | | physician's or pharmacist's conduct. |
|---|
| 49 | 49 | | SECTION 2. The changes in law made by this Act apply only to |
|---|
| 50 | 50 | | a prescription issued or a prescription drug promoted, |
|---|
| 51 | 51 | | administered, or dispensed on or after the effective date of this |
|---|
| 52 | 52 | | Act. |
|---|
| 53 | 53 | | SECTION 3. This Act takes effect September 1, 2025. |
|---|